Dr. Amy Abernethy, principal deputy commissioner at the U.S. FDA, discusses the FDA's role in balancing innovation, regulation and safety during the coronavirus pandemic. EMEA By HIMSS TV | September 15, 2020 | 6:08 PM Tags: Women in Health IT, FutureMed 2020, FDA, COVID-19, Coronavirus
